XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segments - Segments in Significant Accounting Policies (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Segment Reporting Information          
Depreciation and amortization $ 8,445 $ 7,918 $ 24,300 $ 24,042  
Reconciliation of income before income taxes to Adjusted EBITDA          
Interest expense, net 2,925 2,933 8,767 8,957  
Depreciation and amortization 8,445 7,918 24,300 24,042  
Acquisition-related costs of goods sold 78 0 78    
Acquisition-related transaction costs 279 0 279    
(Gain) on sale of investment   0 (1,203)    
Stock-based compensation   0 0 1,129  
Foreign currency (gains), net (10,564) (583) (12,625) (3,590)  
Identifiable assets 916,181   916,181   $ 841,325
Operating Segments          
Segment Reporting Information          
Net sales 239,619 211,729 686,996 613,072  
Depreciation and amortization 8,032 7,519 23,124 22,802  
Adjusted EBITDA 39,400 39,123 114,253 114,043  
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 26,833 17,782 59,958 50,343  
Interest expense, net 2,925 2,933 8,767 8,957  
Depreciation and amortization 8,032 7,519 23,124 22,802  
Corporate costs 11,404 11,073 34,699 33,162  
Foreign currency (gains), net (10,564) (583) (12,625) (3,590)  
Adjusted EBITDA - Total segments 39,400 39,123 114,253 114,043  
Identifiable assets 768,263   768,263   699,500
Operating Segments | Animal Health          
Segment Reporting Information          
Net sales 148,589 134,380 440,520 398,987  
Depreciation and amortization 6,935 6,457 19,872 19,476  
Adjusted EBITDA 29,232 30,962 90,565 94,412  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 6,935 6,457 19,872 19,476  
Adjusted EBITDA - Total segments 29,232 30,962 90,565 94,412  
Identifiable assets 647,490   647,490   595,315
Operating Segments | Mineral Nutrition          
Segment Reporting Information          
Net sales 69,033 58,153 190,120 163,750  
Depreciation and amortization 661 646 1,960 2,042  
Adjusted EBITDA 7,303 5,232 17,361 12,464  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 661 646 1,960 2,042  
Adjusted EBITDA - Total segments 7,303 5,232 17,361 12,464  
Identifiable assets 82,378   82,378   67,338
Operating Segments | Performance Products          
Segment Reporting Information          
Net sales 21,997 19,196 56,356 50,335  
Depreciation and amortization 436 416 1,292 1,284  
Adjusted EBITDA 2,865 2,929 6,327 7,167  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 436 416 1,292 1,284  
Adjusted EBITDA - Total segments 2,865 2,929 6,327 7,167  
Identifiable assets 38,395   38,395   36,847
Corporate          
Segment Reporting Information          
Depreciation and amortization 413 399 1,176 1,240  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 413 $ 399 1,176 $ 1,240  
Identifiable assets $ 147,918   $ 147,918   $ 141,825